Skip to main content
. Author manuscript; available in PMC: 2015 Jan 13.
Published in final edited form as: Invest New Drugs. 2014 Mar 27;32(4):739–745. doi: 10.1007/s10637-014-0083-8

Figure 1.

Figure 1

Analysis of HeyL gene expression via PCR on matched pre- and post-treatment (day 17) tumor biopsies in subjects (n=3) treated with RO4929097, showing a trend of decreased expression (p=0.08)